3-D Matrix,Ltd. (7777) Other
Market cap
¥54.7B
P/E ratio
59.2x
Three-D Matrix develops and sells medical devices and pharmaceuticals using exclusive MIT-licensed self-assembling peptide technology for surgery, tissue regeneration, and drug delivery.
| 2012/04 | 2013/04 | 2014/04 | 2015/04 | 2016/04 | 2017/04 | 2018/04 | 2019/04 | 2020/04 | 2021/04 | 2022/04 | 2023/04 | 2024/04 | 2025/04 | |
| Return on Assets | - | - | - | - | -9.5 | -3.3 | -17.8 | -18.2 | -26.6 | -13.5 | 3.9 | -6.3 | 7.6 | -40.3 |
| Return on equity (%) | - | - | - | |||||||||||
| Employees | 22 | 28 | 35 | 33 | 38 | 37 | 42 | 55 | 65 | 69 | 85 | 108 | 106 | 114 |